Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report

Sarah Shalhoub; Abdulwahab AlZahrani; Raed Simhairi; Adnan Mushtaq

doi:10.1016/j.jcv.2014.11.030

Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report

J Clin Virol. 2015 Jan:62:69-71. doi: 10.1016/j.jcv.2014.11.030. Epub 2014 Nov 29.

Authors

Sarah Shalhoub¹, Abdulwahab AlZahrani², Raed Simhairi², Adnan Mushtaq³

Affiliations

¹ King Fahad Armed Forces Hospital, P.O. Box 2231, Jeddah 21451, Saudi Arabia. Electronic address: sarah.shalhoub@googlemail.com.
² Molecular Laboratory, Medical Microbiology, King Fahad Armed Forces Hospital, Saudi Arabia.
³ King Fahad Armed Forces Hospital, P.O. Box 2231, Jeddah 21451, Saudi Arabia.

Abstract

Middle East Respiratory Syndrome Coronavirus (MERS CoV) may cause severe pneumonia with significant morbidity and mortality, particularly in patients with multiple comorbid condition. MERS CoV pneumonia has not been previously reported in patients with Human Immunodeficiency Virus (HIV). Herein, we report a case of MERS CoV pneumonia with a successful outcome in a patient recently diagnosed with HIV.

Keywords: HIV; Immunodeficiency; MERS; Pneumonia.

Publication types

Case Reports
Review

MeSH terms

Acquired Immunodeficiency Syndrome / complications*
Acquired Immunodeficiency Syndrome / diagnosis
Acquired Immunodeficiency Syndrome / drug therapy
Antiretroviral Therapy, Highly Active
Antiviral Agents / therapeutic use
Coronavirus Infections / complications*
Coronavirus Infections / diagnosis
Coronavirus Infections / drug therapy*
Humans
Male
Middle Aged
Middle East Respiratory Syndrome Coronavirus* / genetics
Pneumonia, Viral / complications*
Pneumonia, Viral / diagnosis
Pneumonia, Viral / drug therapy*
Radiography, Thoracic
Steroids / therapeutic use
Treatment Outcome

Substances

Antiviral Agents
Steroids